<p><strong>美敦力</strong>（MDT -0.68%）今天不太受欢迎，尽管其历史上股息收益率约为 3%。不过，该公司正在努力改善其业务表现，预计将会有更强劲的业绩。这可能使美敦力成为今天你可以购买的最佳医疗保健股票之一。</p>
<h2>美敦力处于低迷状态</h2>
<p>作为一家医疗设备制造商，投资于研发是美敦力业务的关键方面。然而，研发本身就是一个不稳定的努力，更不用说它是一个耗时且昂贵的过程。今天围绕美敦力的低迷看法至少部分与其经历了一个发展干旱期有关。然而，随着公司新的外科手术机器人和心脏消融系统开始获得关注，这种情况正在开始改变。</p>
<p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy84MzAyMDgvMjRfMDlfMTQtd29vZGVuLWJsb2Nrcy1zcGVsbGluZy1vdXQtYnVsbC1hbmQtYmVhci1fbWYtZGxvYWQtZ2V0dHlpbWFnZXMtMTMxNjEyOTA3NC0xMjAxeDY1Ni05Y2ZmNDcyLmpwZyZ3PTcwMA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy84MzAyMDgvMjRfMDlfMTQtd29vZGVuLWJsb2Nrcy1zcGVsbGluZy1vdXQtYnVsbC1hbmQtYmVhci1fbWYtZGxvYWQtZ2V0dHlpbWFnZXMtMTMxNjEyOTA3NC0xMjAxeDY1Ni05Y2ZmNDcyLmpwZyZ3PTcwMA"/></p>
<p>图片来源：Getty Images。</p>
<p>然而，这只是围绕美敦力投资论点的开始。它还试图专注于其最盈利的业务。在这方面的下一个重大举措将是剥离其糖尿病治疗部门，这将立即增加收益。这是因为医疗巨头其他业务（心血管、外科医疗和神经科学领域）的利润率高于糖尿病部门。</p>
<p>然而，从大局来看，随着新产品的上线，该公司的盈利增长可能会快于华尔街目前的预期。更高的利润率本质上应该有助于加速来自研发开发的收入增长。总的来说，你今天可以获得高收益，同时等待投资者跟上美敦力业务改善的基本面。当他们跟上时，市场可能会迅速从对该股票的看跌转向看涨。</p>

美敦力

<p>美敦力（MDT）目前被低估，尽管其股息收益率约为 3%。该公司正在通过新的外科手术机器人和心脏消融系统来提升业务表现。计划中的糖尿病部门分拆预计将提升盈利，因为剩余部门的利润率更高。随着新产品的推出，美敦力的盈利增长可能会超出华尔街的预期，从而可能将市场情绪从看跌转向看涨</p>

<p><strong>Medtronic</strong>(MDT -0.68%) is out of favor today, noting it has a historically high dividend yield of around 3%. The company is working on improving its business performance, however, and stronger results are likely on tap. That could make Medtronic one of the best healthcare stocks you can buy today.</p>
<div class="lb-trans"><p><strong>美敦力</strong>（MDT -0.68%）今天不太受欢迎，尽管其历史上股息收益率约为 3%。不过，该公司正在努力改善其业务表现，预计将会有更强劲的业绩。这可能使美敦力成为今天你可以购买的最佳医疗保健股票之一。</p>
</div><h2>Medtronic was in a funk</h2>
<div class="lb-trans"><h2>美敦力处于低迷状态</h2>
</div><p>As a medical device maker, investing in research and development is a key aspect of Medtronic's business. Only R&amp;D is an inherently lumpy effort, not to mention a time-consuming and expensive one. At least part of the downbeat view around Medtronic today is related to the fact that it went through a development dry spell. That, however, is beginning to change with the company's new surgical robots and cardiac ablation systems starting to gain traction.</p>
<div class="lb-trans"><p>作为一家医疗设备制造商，投资于研发是美敦力业务的关键方面。然而，研发本身就是一个不稳定的努力，更不用说它是一个耗时且昂贵的过程。今天围绕美敦力的低迷看法至少部分与其经历了一个发展干旱期有关。然而，随着公司新的外科手术机器人和心脏消融系统开始获得关注，这种情况正在开始改变。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy84MzAyMDgvMjRfMDlfMTQtd29vZGVuLWJsb2Nrcy1zcGVsbGluZy1vdXQtYnVsbC1hbmQtYmVhci1fbWYtZGxvYWQtZ2V0dHlpbWFnZXMtMTMxNjEyOTA3NC0xMjAxeDY1Ni05Y2ZmNDcyLmpwZyZ3PTcwMA" alt="" original-src="https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F830208%2F24_09_14-wooden-blocks-spelling-out-bull-and-bear-_mf-dload-gettyimages-1316129074-1201x656-9cff472.jpg&amp;op=resize&amp;w=700"/></p>
<p>Image source: Getty Images.</p>
<div class="lb-trans"><p>图片来源：Getty Images。</p>
</div><p>That, however, is just the start of the investment thesis around Medtronic. It has also been attempting to focus on its most profitable businesses. The next big move on this front will be the spinoff of its diabetes treatment division, which will be immediately accretive to earnings. That's because the rest of the healthcare giant's businesses (in the cardiovascular, medical surgical, and neuroscience niches) have higher profit margins than does the diabetes division.</p>
<div class="lb-trans"><p>然而，这只是围绕美敦力投资论点的开始。它还试图专注于其最盈利的业务。在这方面的下一个重大举措将是剥离其糖尿病治疗部门，这将立即增加收益。这是因为医疗巨头其他业务（心血管、外科医疗和神经科学领域）的利润率高于糖尿病部门。</p>
</div><p>The big picture here, however, is that as new products come on line, the company's earnings growth could be faster than Wall Street is currently expecting. Higher profit margins, essentially, should help supercharge the increased revenues from R&amp;D developments. All in, you get to collect a high yield today while you wait for investors to catch up to the improving fundamentals of Medtronic's business. When they do catch up, the market could quickly go from being bearish on the stock to being bullish.</p>
<div class="lb-trans"><p>然而，从大局来看，随着新产品的上线，该公司的盈利增长可能会快于华尔街目前的预期。更高的利润率本质上应该有助于加速来自研发开发的收入增长。总的来说，你今天可以获得高收益，同时等待投资者跟上美敦力业务改善的基本面。当他们跟上时，市场可能会迅速从对该股票的看跌转向看涨。</p>
</div>

美敦力（MDT）是您今天可以购买的最佳医疗保健股票之一的原因之一